Bruce G. Allen Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8
Closed -$288 1132
2024
Q4
$288 Hold
8
﹤0.01% 1038
2024
Q3
$339 Hold
8
﹤0.01% 1026
2024
Q2
$322 Hold
8
﹤0.01% 901
2024
Q1
$283 Hold
8
﹤0.01% 909
2023
Q4
$237 Buy
+8
New +$166 ﹤0.01% 980

Other funds holding TNDM

Bruce G. Allen Investments's TNDM Position: Q1 2025 in Review

Bruce G. Allen Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 8 shares — an estimated $288 sold.

Bruce G. Allen Investments first reported a position in TNDM in Q4 2023 and held it in 5 quarters. The position peaked at $339 in Q3 2024. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Bruce G. Allen Investments reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Bruce G. Allen Investments sold 8 Tandem Diabetes Care shares in Q1 2025, an estimated $288.
  • Bruce G. Allen Investments first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 5 quarters.
  • Bruce G. Allen Investments's Tandem Diabetes Care position peaked at $339 in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Bruce G. Allen Investments's 13F filing for Q1 2025, filed 14 Apr 2025.